Bose G - Search Results

1

Serum neurofilament light in MS: The first true blood-based biomarker?

Thebault S, Bose G, Booth R, Freedman MS. Thebault S, et al. Among authors: bose g. Mult Scler. 2022 Sep;28(10):1491-1497. doi: 10.1177/1352458521993066. Epub 2021 Feb 10. Mult Scler. 2022. PMID: 33565908 Free PMC article. Review.

2

Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis.

Bose G, Atkins HL, Bowman M, Freedman MS. Bose G, et al. Mult Scler. 2019 Nov;25(13):1764-1772. doi: 10.1177/1352458518802544. Epub 2018 Sep 25. Mult Scler. 2019. PMID: 30251913 Clinical Trial.

3

Does Resetting the Immune System Fix Multiple Sclerosis?

Bose G, Thebault SDX, Atkins HL, Freedman MS. Bose G, et al. Can J Neurol Sci. 2020 Jan;47(1):1-10. doi: 10.1017/cjn.2019.294. Epub 2019 Oct 18. Can J Neurol Sci. 2020. PMID: 31511117

4

Precision medicine in the multiple sclerosis clinic: Selecting the right patient for the right treatment.

Bose G, Freedman MS. Bose G, et al. Mult Scler. 2020 Apr;26(5):540-547. doi: 10.1177/1352458519887324. Epub 2020 Jan 22. Mult Scler. 2020. PMID: 31965903 Review.

5

Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis.

Thebault S, Lee H, Bose G, Tessier D, Abdoli M, Bowman M, Berard J, Walker L, Rush CA, MacLean H, Booth RA, Narayanan S, Arnold DL, Tabard-Cossa V, Atkins HL, Bar-Or A, Freedman MS. Thebault S, et al. Among authors: bose g. Ann Clin Transl Neurol. 2020 May;7(5):767-775. doi: 10.1002/acn3.51045. Epub 2020 Apr 18. Ann Clin Transl Neurol. 2020. PMID: 32304358 Free PMC article.

6

Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective.

Bose G, Thebault S, Rush CA, Atkins HL, Freedman MS. Bose G, et al. Mult Scler. 2021 Feb;27(2):167-173. doi: 10.1177/1352458520917936. Epub 2020 May 4. Mult Scler. 2021. PMID: 32364422

7

Recent advances and remaining questions of autologous hematopoietic stem cell transplantation in multiple sclerosis.

Bose G, Freedman MS. Bose G, et al. J Neurol Sci. 2021 Feb 15;421:117324. doi: 10.1016/j.jns.2021.117324. Epub 2021 Jan 18. J Neurol Sci. 2021. PMID: 33497951 Review.

8

A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis.

Bose G, Rush C, Atkins HL, Freedman MS. Bose G, et al. Mult Scler Relat Disord. 2021 Jul;52:102945. doi: 10.1016/j.msard.2021.102945. Epub 2021 Apr 11. Mult Scler Relat Disord. 2021. PMID: 33901969

9

Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis.

Bose G, Healy BC, Barro C, Moreira Ferreira VF, Saxena S, Glanz BI, Lokhande HA, Polgar-Turcsanyi M, Bakshi R, Weiner HL, Chitnis T. Bose G, et al. Mult Scler. 2023 Oct;29(11-12):1418-1427. doi: 10.1177/13524585231198751. Epub 2023 Sep 15. Mult Scler. 2023. PMID: 37712409

10

Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.

Cross AH, Gelfand JM, Thebault S, Bennett JL, von Büdingen HC, Cameron B, Carruthers R, Edwards K, Fallis R, Gerstein R, Giacomini PS, Greenberg B, Hafler DA, Ionete C, Kaunzner UW, Kodama L, Lock C, Longbrake EE, Musch B, Pardo G, Piehl F, Weber MS, Yuen S, Ziemssen T, Bose G, Freedman MS, Anania VG, Ramesh A, Winger RC, Jia X, Herman A, Harp C, Bar-Or A. Cross AH, et al. Among authors: bose g. JAMA Neurol. 2024 Mar 11;81(4):373-83. doi: 10.1001/jamaneurol.2024.0017. Online ahead of print. JAMA Neurol. 2024. PMID: 38466277 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page